Di Renzo M F, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R, Pierotti M A
Department of Biomedical Science and Oncology, University of Torino Medical School, Italy.
Oncogene. 1992 Dec;7(12):2549-53.
The receptor for Hepatocyte Growth Factor is a transmembrane tyrosine kinase encoded by the c-MET oncogene. We have previously shown that the Met protein is expressed in several human epithelial tissues. The receptor is barely detectable, however, in normal thyroids and in specimens from patients affected by non-neoplastic thyroid diseases. Now we report that the expression of the Met/HGF receptor is increased a hundred fold in 22 out of 41 human carcinomas derived from the thyroid follicular epithelium. A comprehensive analysis of 15 cases showed that the overexpressing carcinomas belong to histotype variants correlated with negative prognosis and in all but one case there were evidences of locally advanced disease and/or distant metastases. The 11 benign adenomas and the 5 medullary carcinomas tested were negative. Western blot analysis with monoclonal antibodies directed against either the intracellular or the extracellular receptor domains failed to reveal major structural alterations. Southern blot analysis also demonstrated that the c-MET gene was not amplified nor rearranged. These data suggest a role for the overexpression of c-MET oncogene in the pathogenesis and progression of thyroid tumors derived from the follicular epithelium.
肝细胞生长因子的受体是一种由c-MET癌基因编码的跨膜酪氨酸激酶。我们之前已经表明,Met蛋白在几种人类上皮组织中表达。然而,在正常甲状腺以及非肿瘤性甲状腺疾病患者的标本中,该受体几乎检测不到。现在我们报告,在41例源自甲状腺滤泡上皮的人类癌组织中,有22例Met/HGF受体的表达增加了100倍。对15例病例的综合分析表明,过表达的癌组织属于与不良预后相关的组织学类型变体,除1例病例外,所有病例均有局部晚期疾病和/或远处转移的证据。所检测的11例良性腺瘤和5例髓样癌均为阴性。用针对细胞内或细胞外受体结构域的单克隆抗体进行的蛋白质印迹分析未能揭示主要的结构改变。Southern印迹分析也表明,c-MET基因未扩增也未重排。这些数据表明,c-MET癌基因的过表达在源自滤泡上皮的甲状腺肿瘤的发病机制和进展中起作用。